APPLICATION
ANDA074513
TYPE
ANDA
ORIGINAL APPROVAL
1996-03-14
LATEST ACTION
2011-02-24
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
ETOPOSIDEPrescription
ETOPOSIDE 20MG/ML · INJECTABLE · INJECTION
Approval history
2011-02-24Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.